Capacity Bio, Inc. — Form D
Capacity Bio, Inc. of PALO ALTO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-18. The offering totals $35.3M, of which $19.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-01-18
- Form: D
- Accession: 0001960587-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $35.3M
- Amount sold: $19.2M
- Remaining: $16.1M
- Investors: 13
- Date of first sale: 2022-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-470977
Issuer
- Name: Capacity Bio, Inc.
- CIK: 0001960587
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 3175 HANOVER ST., PALO ALTO, CA, 94304
- Phone: (650) 814-1639
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Cristina Ghenoiu | Director | Palo Alto, CA |
| Kenneth Horne | Director | Palo Alto, CA |
| Taro Inaba | Director | TOKYO, M0 |
| DYLAN MORRIS | Director | Watertown, MA |
| Amy Wang | Director | Palo Alto, CA |
| Kenneth Horne | Executive Officer | Palo Alto, CA |
| Amy Wang | Executive Officer | Palo Alto, CA |
More